Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Combined preconditioning and in vivo chemoselection with 6-thioguanine alone achieves highly efficient reconstitution of normal hematopoiesis with HPRT-deficient bone marrow.

Hacke K, Szakmary A, Cuddihy AR, Rozengurt N, Lemp NA, Aubrecht J, Lawson GW, Rao NP, Crooks GM, Schiestl RH, Kasahara N.

Exp Hematol. 2012 Jan;40(1):3-13.e3. doi: 10.1016/j.exphem.2011.09.009. Epub 2011 Oct 12.

PMID:
22001673
[PubMed - indexed for MEDLINE]
2.

Genetic modification of mouse bone marrow by lentiviral vector-mediated delivery of hypoxanthine-Guanine phosphoribosyltransferase short hairpin RNA confers chemoprotection against 6-thioguanine cytotoxicity.

Hacke K, Treger JA, Bogan BT, Schiestl RH, Kasahara N.

Transplant Proc. 2013 Jun;45(5):2040-4. doi: 10.1016/j.transproceed.2013.01.020.

PMID:
23769104
[PubMed - indexed for MEDLINE]
3.

Tissue specific toxicities of the anticancer drug 6-thioguanine is dependent on the Hprt status in transgenic mice.

Aubrecht J, Goad ME, Schiestl RH.

J Pharmacol Exp Ther. 1997 Aug;282(2):1102-8.

PMID:
9262380
[PubMed - indexed for MEDLINE]
Free Article
4.

Knockdown of HPRT for selection of genetically modified human hematopoietic progenitor cells.

Choudhary R, Baturin D, Fosmire S, Freed B, Porter CC.

PLoS One. 2013;8(3):e59594. doi: 10.1371/journal.pone.0059594. Epub 2013 Mar 15.

PMID:
23555045
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Interfering RNA-mediated purine analog resistance for in vitro and in vivo cell selection.

Porter CC, DeGregori J.

Blood. 2008 Dec 1;112(12):4466-74. doi: 10.1182/blood-2008-03-146571. Epub 2008 Jun 27.

PMID:
18587011
[PubMed - indexed for MEDLINE]
Free PMC Article
6.
7.
8.

The contribution of cytotoxic and noncytotoxic function by donor T-cells that support engraftment after allogeneic bone marrow transplantation.

Jiang Z, Adams GB, Hanash AM, Scadden DT, Levy RB.

Biol Blood Marrow Transplant. 2002;8(11):588-96.

PMID:
12463477
[PubMed - indexed for MEDLINE]
9.

Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents.

Neben S, Hellman S, Montgomery M, Ferrara J, Mauch P.

Exp Hematol. 1993 Jan;21(1):156-62. Erratum in: Exp Hematol 1993 Feb;21(2):following 398. Hemman S [corrected to Hellman S].

PMID:
8435103
[PubMed - indexed for MEDLINE]
10.

A STAT5 modifier locus on murine chromosome 7 modulates engraftment of hematopoietic stem cells during steady-state hematopoiesis.

Couldrey C, Bradley HL, Bunting KD.

Blood. 2005 Feb 15;105(4):1476-83. Epub 2004 Oct 21.

PMID:
15498858
[PubMed - indexed for MEDLINE]
Free Article
12.

6-Thioguanine-induced growth arrest in 6-mercaptopurine-resistant human leukemia cells.

Morgan CJ, Chawdry RN, Smith AR, Siravo-Sagraves G, Trewyn RW.

Cancer Res. 1994 Oct 15;54(20):5387-93.

PMID:
7923170
[PubMed - indexed for MEDLINE]
Free Article
13.

Flow cytometric enumeration of drug-resistant tumor cells.

deFazio A, Musgrove EA, Tattersall MH.

Cancer Res. 1988 Nov 1;48(21):6037-43.

PMID:
3167854
[PubMed - indexed for MEDLINE]
Free Article
14.

Methotrexate preconditioning allows sufficient engraftment to confer drug resistance in mice transplanted with marrow expressing drug-resistant dihydrofolate reductase activity.

Belur LR, James RI, May C, Diers MD, Swanson D, Gunther R, McIvor RS.

J Pharmacol Exp Ther. 2005 Aug;314(2):668-74. Epub 2005 Apr 27.

PMID:
15857949
[PubMed - indexed for MEDLINE]
Free Article
15.

Selection against blood cells deficient in hypoxanthine phosphoribosyltransferase (HPRT) in Lesch-Nyhan heterozygotes occurs at the level of multipotent stem cells.

Hakoda M, Hirai Y, Akiyama M, Yamanaka H, Terai C, Kamatani N, Kashiwazaki S.

Hum Genet. 1995 Dec;96(6):674-80.

PMID:
8522326
[PubMed - indexed for MEDLINE]
16.

Comparison of different busulfan analogues for depletion of hematopoietic stem cells and promotion of donor-type chimerism in murine bone marrow transplant recipients.

Westerhof GR, Ploemacher RE, Boudewijn A, Blokland I, Dillingh JH, McGown AT, Hadfield JA, Dawson MJ, Down JD.

Cancer Res. 2000 Oct 1;60(19):5470-8.

PMID:
11034090
[PubMed - indexed for MEDLINE]
Free Article
17.

The isolation and preliminary characterisation of 6-thioguanine-resistant mutants of human diploid fibroblasts.

Cox R, Masson WK.

Mutat Res. 1976 Jul;36(1):93-104.

PMID:
950955
[PubMed - indexed for MEDLINE]
18.

Neonatal bone marrow transplantation of ADA-deficient SCID mice results in immunologic reconstitution despite low levels of engraftment and an absence of selective donor T lymphoid expansion.

Carbonaro DA, Jin X, Cotoi D, Mi T, Yu XJ, Skelton DC, Dorey F, Kellems RE, Blackburn MR, Kohn DB.

Blood. 2008 Jun 15;111(12):5745-54. doi: 10.1182/blood-2007-08-103663. Epub 2008 Mar 20.

PMID:
18356486
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Isolation and characterization of HPRT-deficient human hepatoma cells.

Porter MB, Fournier RE.

Somat Cell Mol Genet. 1996 Jul;22(4):341-8.

PMID:
9000176
[PubMed - indexed for MEDLINE]
20.

A novel mouse model of veno-occlusive disease provides strategies to prevent thioguanine-induced hepatic toxicity.

Oancea I, Png CW, Das I, Lourie R, Winkler IG, Eri R, Subramaniam N, Jinnah HA, McWhinney BC, Levesque JP, McGuckin MA, Duley JA, Florin TH.

Gut. 2013 Apr;62(4):594-605. doi: 10.1136/gutjnl-2012-302274. Epub 2012 Jul 7.

PMID:
22773547
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk